Roche enters into a definitive merger agreement to acquire 89bio
Basel, 18 September 2025 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has entered into a definitive merger agreement to acquire 89bio, Inc. (Nasdaq: ETNB), a publicly [..]